Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • WHEELER CM
    • BOUCHARD C
    • MARTENS MG
    • MONEY DM
    • QUEK SC
    • ROMANOWSKI B
    • VALLEJOS CS
    • TER HARMSEL B
    • PRILEPSKAYA V
    • FONG KL
    • KITCHENER H
    • SKINNER SR
    • MINKINA G
    • LIM YKT
    • STONEY T
    • CHAKHTOURA N
    • CRUICKSHANK ME
    • SAVICHEVA A
    • DA SILVA DP
    • FERGUSON M
    • MOLIJN AC
    • QUINT WGV
    • ROWENA DEL ROSARIO-RAYMUNDO M
    • HARDT K
    • DESCAMPS D
    • SURYAKIRAN PV
    • KARKADA N
    • GEERAERTS B
    • DUBIN G
    • STRUYF F
    • PROF Suzanne Garland Wark
    • CHATTERJEE A
    • LAZCANO-PONCE E
    • SALMERON J
    • MCNEIL S
    • STAPLETON JT

Published in

  • The Lancet Infectious Diseases

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1473-3099(16)30120-7

Additional Document Info

Parent Title

  • LANCET INFECTIOUS DISEASES

Volume

  • 16

Issue

  • 10

Publisher

  • The Lancet Publishing Group